Definium Therapeutics DFTX Balance Sheet (2020-2026)

NASDAQ DFTX
$38.09 +0.09 (+0.24%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Definium Therapeutics Quarterly Balance Sheet

Periods 23 quarters
Latest Jun 2026

Definium Therapeutics reported total assets of $1112.90M and total liabilities of $194.22M for the quarter ended Jun 2026, up 319.8% year over year. This balance sheet covers 23 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
133.54M105.74M154.52M142.14M129.41M116.89M117.70M99.70M252.33M243.13M295.28M273.74M82.85M33.39M19.96M257.84M262.52M655.27M
Prepaid Assets
3.68M2.75M3.17M1.83M3.91M3.00M2.90M2.39M4.17M3.14M4.56M4.07M7.88M9.26M6.14M6.78M7.73M7.14M8.22M
Current Assets
137.22M123.23M109.09M156.51M146.06M132.41M119.79M120.09M103.87M255.47M247.69M299.36M281.62M221.70M189.14M215.85M419.32M380.56M1,092.10M
Non-Current Assets
Long-Term Investments
33.10M54.90M
Goodwill
19.92M19.92M19.92M19.92M19.92M19.92M19.92M19.92M19.92M19.92M
Intangibles
6.87M6.09M5.27M4.48M3.69M2.90M2.11M1.32M0.53M
Goodwill & Intangibles
26.79M26.01M5.27M4.48M23.61M22.82M2.11M1.32M20.45M19.92M19.92M19.92M19.92M19.92M
Other Non-Current Assets
0.33M0.30M0.27M0.23M0.22M0.14M0.53M0.49M0.61M0.61M1.17M1.15M0.86M0.81M0.88M
Non-Current Assets
26.79M26.01M25.19M24.40M23.94M23.12M22.29M21.46M20.67M20.06M20.45M20.41M20.53M53.62M75.95M21.07M20.78M20.73M20.80M
Assets
164.00M149.23M134.28M180.91M169.99M155.53M142.09M141.55M124.54M275.53M268.14M319.77M302.15M275.32M265.09M236.92M440.10M401.29M1,112.90M
Liabilities
Current Liabilities
Accounts Payables
4.18M3.33M0.73M0.82M2.11M2.32M8.58M7.69M4.14M7.59M2.94M2.15M2.01M2.27M4.22M8.11M5.35M7.13M6.96M
Payables
4.18M3.33M0.73M0.82M2.11M2.32M8.58M7.69M4.14M7.59M2.94M2.15M2.01M2.27M4.22M8.11M5.35M7.13M6.96M
Accumulated Expenses
6.23M7.23M7.14M7.47M5.88M6.69M9.95M9.96M11.63M9.97M8.23M8.80M12.83M11.50M14.80M19.03M20.45M24.51M37.22M
Other Accumulated Expenses
0.00M0.04M0.23M0.09M0.07M0.09M0.09M0.44M0.36M0.29M0.69M0.31M0.28M0.26M0.46M0.50M0.51M0.60M0.56M
Total Current Liabilities
10.41M10.56M7.87M26.04M17.89M24.10M35.12M31.15M32.25M65.27M41.85M33.27M38.85M30.48M37.96M65.42M66.70M81.11M157.20M
Non-Current Liabilities
Non-Current Debt
14.07M14.13M14.19M24.25M24.31M21.85M22.04M41.19M40.38M40.58M40.77M36.47M
Other Non-Current Liabilities
1.93M0.49M1.90M1.28M1.18M1.09M0.99M0.35M0.03M0.01M30.68M22.32M25.16M17.84M0.54M0.52M0.50M0.56M0.55M
Total Non-Current Liabilities
10.41M11.94M7.87M26.04M17.89M24.10M35.12M45.22M46.38M79.46M35.42M35.26M35.55M34.67M79.15M105.80M107.28M121.89M193.67M
Total Liabilities
-164.27M12.34M12.43M9.77M27.31M19.08M25.18M36.11M45.57M46.41M79.47M66.10M57.58M60.70M52.52M79.69M106.32M107.77M122.44M194.22M
Shareholder's Equity
Total Debt
14.07M14.13M14.19M24.25M24.31M21.85M22.04M41.19M40.38M40.58M40.77M36.47M
Common Equity
164.27M151.66M136.81M124.50M153.59M150.92M130.34M105.97M95.98M78.13M196.06M202.05M262.19M241.45M222.81M185.40M130.60M332.33M278.85M918.68M
Liabilities and Shareholders Equity
164.00M149.23M134.28M180.91M169.99M155.53M142.09M141.55M124.54M275.53M268.14M319.77M302.15M275.32M265.09M236.92M440.10M401.29M1,112.90M
Retained Earnings
-137.67M-156.12M-173.10M-189.60M-194.47M-219.30M-248.41M-266.34M-290.20M-344.60M-350.50M-364.14M-398.88M-422.23M-465.00M-532.24M-582.67M-659.80M-818.80M